Hepatic Mitochondrial Metabolism in Fatty Liver Diseases in Humans
Bidragets beskrivning
Fatty liver diseases (FLDs) related to obesity and alcohol use affect up to a quarter of the population, but their pathogenesis is poorly understood, and available medications are scarce. In this series of studies, we will investigate the energy motors of the liver – mitochondria – and their dysfunction as a key mechanism in the pathogenesis of FLDs. We will study mitochondrial dysfunction in FLD patients before and after distinct treatments by using the newest, safe tracer-based techniques. We will also use these precise techniques to study the effects of acquired risk factors of FLDs on hepatic mitochondrial function. In addition, we will investigate the association between hepatic mitochondrial dysfunction and FLDs in large population-based cohorts. These studies are expected to provide important new information on the pathogenesis of FLDs with respect to acquired and inherited risk factors. The results may also help in the development of new medical therapies for FLDs.
Visa merStartår
2022
Slutår
2026
Beviljade finansiering
Finansiär
Finlands Akademi
Typ av finansiering
Kliniska forskare
Utlysning
Beslutfattare
Forskningsrådet för biovetenskap, hälsa och miljö
30.05.2022
30.05.2022
Övriga uppgifter
Finansieringsbeslutets nummer
350545
Forskningsområden
Kliiniset lääketieteet
Identifierade teman
diabetes, medicine, metabolic diseases